Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Novartis |
---|---|
Information provided by: | Novartis |
ClinicalTrials.gov Identifier: | NCT00409760 |
This trial will compare valsartan and amlodipine combination therapies to both valsartan and amlodipine, and placebo for the treatment of hypertension.
Condition | Intervention | Phase |
---|---|---|
Hypertension |
Drug: valsartan+amlodipine combination, valsartan, amlodipine |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Double-Blind, Multicenter, Multifactorial, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients. |
Estimated Enrollment: | 1850 |
Study Start Date: | August 2005 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | CVAA489A2201 |
Study First Received: | December 7, 2006 |
Last Updated: | July 6, 2007 |
ClinicalTrials.gov Identifier: | NCT00409760 History of Changes |
Health Authority: | United States: Food and Drug Administration |
HYEPRTENSION, VALSARTAN, AMLODIPINE, high blood pressure |
Calcium, Dietary Vasodilator Agents Vascular Diseases Calcium Channel Blockers Cardiovascular Agents |
Antihypertensive Agents Valsartan Amlodipine Hypertension |
Vasodilator Agents Molecular Mechanisms of Pharmacological Action Vascular Diseases Calcium Channel Blockers Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions |
Amlodipine Membrane Transport Modulators Therapeutic Uses Cardiovascular Diseases Valsartan Hypertension |